TY - JOUR
T1 - Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice
AU - Nishio, Miki
AU - To, Yoko
AU - Maehama, Tomohiko
AU - Aono, Yukari
AU - Otani, Junji
AU - Hikasa, Hiroki
AU - Kitagawa, Akihiro
AU - Mimori, Koshi
AU - Sasaki, Takehiko
AU - Nishina, Hiroshi
AU - Toyokuni, Shinya
AU - Lydon, John P.
AU - Nakao, Kazuwa
AU - Wah Mak, Tak
AU - Kiyono, Tohru
AU - Katabuchi, Hidetaka
AU - Tashiro, Hironori
AU - Suzuki, Akira
N1 - Funding Information:
Japan Agency for Medical Research and Development (Grant/Award Number: "JP20cm0106114"); Cooperative Research Project Program of the MIB, Kyushu University; Japan Society for the Promotion of Science (Grant/Award Number: "17H01400," "26114005," "26640081"); Nanken-Kyoten, Tokyo Medical and Dental University; Kanzawa Medical Research Foundation. We thank J. Wrana (Lunenfeld-Tanenbaum Research Institute) for Tazflox/flox mice. We are grateful for the funding provided by the Japanese Society for the Promotion of Science (JSPS; grants 17H01400, 26114005, 26640081); the Cooperative Research Project Program of the MIB, Kyushu University; Nanken-Kyoten, Tokyo Medical and Dental University (TMDU); the Japanese Agency for Medical Research and Development [P-CREATE(AMED) grant; JP20cm0106114]; and the Kanzawa Medical Research Foundation.
Funding Information:
We thank J. Wrana (Lunenfeld‐Tanenbaum Research Institute) for Tazflox/flox mice. We are grateful for the funding provided by the Japanese Society for the Promotion of Science (JSPS; grants 17H01400, 26114005, 26640081); the Cooperative Research Project Program of the MIB, Kyushu University; Nanken‐Kyoten, Tokyo Medical and Dental University (TMDU); the Japanese Agency for Medical Research and Development [P‐CREATE(AMED) grant; JP20cm0106114]; and the Kanzawa Medical Research Foundation.
Funding Information:
Japan Agency for Medical Research and Development (Grant/Award Number: "JP20cm0106114"); Cooperative Research Project Program of the MIB, Kyushu University; Japan Society for the Promotion of Science (Grant/Award Number: "17H01400," "26114005," "26640081"); Nanken‐Kyoten, Tokyo Medical and Dental University; Kanzawa Medical Research Foundation.
Publisher Copyright:
© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Cervical cancer (CC) is usually initiated by infection with high-risk types of human papillomavirus (HPV). The HPV E6 and E7 proteins target p53 and RB, respectively, but other cellular targets likely exist. We generated uterus-specific MOB1A/B double KO (uMob1DKO) mice, which immediately developed cervical squamous cell carcinoma in situ. Mutant cervical epithelial cells showed YAP1-dependent hyperproliferation, altered self-renewal, impaired contact inhibition, and chromosomal instability. p53 activation was increased in uMob1DKO cells, and additional p53 loss in uMob1DKO mice accelerated tumor invasion. In human CC, strong YAP1 activation was observed from the precancerous stage. Human cells overexpressing HPV16 E6/E7 showed inactivation of not only p53 and RB but also PTPN14, boosting YAP1 activation. Estrogen, cigarette smoke condensate, and PI3K hyperactivation all increased YAP1 activity in human cervical epithelial cells, and PTPN14 depletion along with PI3K activation or estrogen treatment further enhanced YAP1. Thus, immediate CC onset may initiate when YAP1 activity exceeds an oncogenic threshold, making Hippo-YAP1 signaling a major CC driver.
AB - Cervical cancer (CC) is usually initiated by infection with high-risk types of human papillomavirus (HPV). The HPV E6 and E7 proteins target p53 and RB, respectively, but other cellular targets likely exist. We generated uterus-specific MOB1A/B double KO (uMob1DKO) mice, which immediately developed cervical squamous cell carcinoma in situ. Mutant cervical epithelial cells showed YAP1-dependent hyperproliferation, altered self-renewal, impaired contact inhibition, and chromosomal instability. p53 activation was increased in uMob1DKO cells, and additional p53 loss in uMob1DKO mice accelerated tumor invasion. In human CC, strong YAP1 activation was observed from the precancerous stage. Human cells overexpressing HPV16 E6/E7 showed inactivation of not only p53 and RB but also PTPN14, boosting YAP1 activation. Estrogen, cigarette smoke condensate, and PI3K hyperactivation all increased YAP1 activity in human cervical epithelial cells, and PTPN14 depletion along with PI3K activation or estrogen treatment further enhanced YAP1. Thus, immediate CC onset may initiate when YAP1 activity exceeds an oncogenic threshold, making Hippo-YAP1 signaling a major CC driver.
UR - http://www.scopus.com/inward/record.url?scp=85089563250&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089563250&partnerID=8YFLogxK
U2 - 10.1111/cas.14581
DO - 10.1111/cas.14581
M3 - Article
C2 - 32716083
AN - SCOPUS:85089563250
SN - 1347-9032
VL - 111
SP - 3576
EP - 3587
JO - Cancer Science
JF - Cancer Science
IS - 10
ER -